IGSF22
gene geneOn this page
Also known as FLJ37794IGFN2
Summary
IGSF22 (immunoglobulin superfamily member 22, HGNC:26750) is a protein-coding gene on chromosome 11p15.1, encoding Immunoglobulin superfamily member 22 (Q8N9C0).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 205 total
- MANE Select transcript:
NM_173588
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26750 |
| Approved symbol | IGSF22 |
| Name | immunoglobulin superfamily member 22 |
| Location | 11p15.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ37794, IGFN2 |
| Ensembl gene | ENSG00000179057 |
| Ensembl biotype | protein_coding |
| Entrez | 283284 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding
ENST00000319338, ENST00000412229, ENST00000504981, ENST00000510673, ENST00000513874
RefSeq mRNA: 1 — MANE Select: NM_173588
NM_173588
CCDS: CCDS41625
Canonical transcript exons
ENST00000513874 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001220297 | 18710327 | 18710455 |
| ENSE00001220302 | 18710655 | 18710828 |
| ENSE00002032667 | 18704312 | 18704538 |
| ENSE00002075256 | 18726074 | 18726188 |
| ENSE00003461539 | 18724128 | 18724269 |
| ENSE00003479157 | 18714277 | 18714418 |
| ENSE00003489911 | 18713852 | 18714148 |
| ENSE00003501786 | 18718615 | 18718728 |
| ENSE00003521020 | 18709387 | 18709683 |
| ENSE00003529622 | 18715432 | 18715716 |
| ENSE00003557678 | 18707804 | 18707996 |
| ENSE00003559794 | 18708207 | 18708295 |
| ENSE00003560439 | 18721910 | 18722041 |
| ENSE00003560867 | 18712082 | 18712384 |
| ENSE00003596016 | 18720064 | 18720103 |
| ENSE00003600156 | 18717931 | 18718093 |
| ENSE00003602604 | 18706914 | 18707213 |
| ENSE00003611489 | 18721535 | 18721671 |
| ENSE00003621213 | 18705817 | 18706146 |
| ENSE00003628718 | 18720186 | 18720285 |
| ENSE00003633152 | 18719716 | 18719893 |
| ENSE00003646155 | 18716728 | 18717000 |
| ENSE00003679604 | 18714500 | 18714624 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 82.75.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0217 / max 13.5666, expressed in 7 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 118957 | 0.0217 | 7 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of leg | UBERON:0001511 | 82.75 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.73 | gold quality |
| skin of abdomen | UBERON:0001416 | 79.86 | gold quality |
| zone of skin | UBERON:0000014 | 79.42 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 79.03 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.53 | gold quality |
| buccal mucosa cell | CL:0002336 | 77.12 | gold quality |
| nucleus accumbens | UBERON:0001882 | 76.10 | gold quality |
| pituitary gland | UBERON:0000007 | 74.63 | gold quality |
| adenohypophysis | UBERON:0002196 | 74.12 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 74.03 | silver quality |
| right frontal lobe | UBERON:0002810 | 73.92 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 73.84 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 73.81 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 73.69 | gold quality |
| putamen | UBERON:0001874 | 73.61 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 73.56 | gold quality |
| metanephros cortex | UBERON:0010533 | 72.88 | gold quality |
| thyroid gland | UBERON:0002046 | 72.76 | gold quality |
| hypothalamus | UBERON:0001898 | 72.65 | gold quality |
| endothelial cell | CL:0000115 | 72.57 | silver quality |
| caudate nucleus | UBERON:0001873 | 72.38 | gold quality |
| left ovary | UBERON:0002119 | 72.35 | gold quality |
| prefrontal cortex | UBERON:0000451 | 72.33 | gold quality |
| right ovary | UBERON:0002118 | 72.28 | gold quality |
| gall bladder | UBERON:0002110 | 72.07 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 71.76 | gold quality |
| apex of heart | UBERON:0002098 | 71.73 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 70.95 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 70.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.56 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
11 targeting IGSF22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-1255A | 99.74 | 68.09 | 744 |
| HSA-MIR-1255B-5P | 99.74 | 68.16 | 741 |
| HSA-MIR-378G | 99.71 | 64.90 | 1106 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-2467-3P | 98.65 | 67.18 | 1969 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | igfn1.1 | ENSDARG00000005526 |
| danio_rerio | igfn1.2 | ENSDARG00000075926 |
| danio_rerio | igfn1.4 | ENSDARG00000086028 |
| danio_rerio | igfn1.3 | ENSDARG00000097613 |
Paralogs (11): MYOM2 (ENSG00000036448), FNDC3B (ENSG00000075420), MYBPC2 (ENSG00000086967), MYOM1 (ENSG00000101605), FNDC3A (ENSG00000102531), OBSL1 (ENSG00000124006), MYBPH (ENSG00000133055), MYBPC3 (ENSG00000134571), MYOM3 (ENSG00000142661), MYBPC1 (ENSG00000196091), MYBPHL (ENSG00000221986)
Protein
Protein identifiers
Immunoglobulin superfamily member 22 — Q8N9C0 (reviewed: Q8N9C0)
All UniProt accessions (1): Q8N9C0
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N9C0-1 | 1 | yes |
| Q8N9C0-2 | 2 |
RefSeq proteins (1): NP_775859* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003598 | Ig_sub2 | Domain |
| IPR003599 | Ig_sub | Domain |
| IPR003961 | FN3_dom | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013098 | Ig_I-set | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036116 | FN3_sf | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR040849 | MyBP-C_THB | Domain |
| IPR050964 | Striated_Muscle_Regulatory | Family |
Pfam: PF00041, PF07679, PF18362
UniProt features (20 total): sequence variant 8, domain 6, sequence conflict 3, splice variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N9C0-F1 | 85.34 | 0.62 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 34 (showing top):
USF_C, PAX8_B, MYCMAX_01, USF_01, TCF11_01, IK2_01, USF_02, AP1FJ_Q2, USF2_Q6, ATCTTGC_MIR31, MYC_Q2, MAX_01, ARNT_01, DODD_NASOPHARYNGEAL_CARCINOMA_DN, AR_Q6
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
746 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IGSF22 | SSX7 | Q7RTT5 | 584 |
| IGSF22 | SSX5 | O60225 | 511 |
| IGSF22 | CCDC90B | Q9GZT6 | 487 |
| IGSF22 | IGSF21 | Q96ID5 | 452 |
| IGSF22 | SSX3 | Q99909 | 447 |
| IGSF22 | IGSF3 | O75054 | 404 |
| IGSF22 | SEL1L3 | Q68CR1 | 401 |
| IGSF22 | CCDC43 | Q96MW1 | 400 |
| IGSF22 | IGSF1 | Q8N6C5 | 400 |
| IGSF22 | IGSF6 | O95976 | 398 |
| IGSF22 | IGSF5 | Q9NSI5 | 396 |
| IGSF22 | CCDC171 | Q6TFL3 | 384 |
| IGSF22 | IL9 | P15248 | 378 |
| IGSF22 | IL13 | P35225 | 376 |
| IGSF22 | CCL5 | P13501 | 375 |
| IGSF22 | IL17A | Q16552 | 375 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IGSF22 | Dlg4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (3): IGF2R (Cross-Linking-MS (XL-MS)), NDUFA9 (Cross-Linking-MS (XL-MS)), IGSF22 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WV53, A2AAJ9, A2ABU4, A2RUH7, E7F6H7, O00423, O01761, O14576, O54785, O70468, O88485, O88599, P16419, P22607, P26453, P52179, P53670, P53671, P54296, P56741, P70402, Q00872, Q02173, Q05623, Q05BC3, Q0DYP5, Q13203, Q14168, Q14324, Q14896, Q29RQ3, Q32L23, Q4V8C3, Q5FW53, Q5PQM4, Q5VST9, Q5VTT5, Q5XI81, Q5XKE0, Q60992
Diamond homologs: A0A087WV53, A2ASS6, A2CG49, A2RUH7, F1M0Z1, O08775, O60229, O70468, O75962, O88599, O94856, P11799, P16419, P35918, P56741, P70402, P97685, P97924, Q00872, Q05623, Q0KL02, Q13203, Q14324, Q14896, Q15746, Q5FW53, Q5PQM4, Q5VTT5, Q5XKE0, Q63518, Q696W0, Q6GMZ9, Q7T2H2, Q8N9C0, Q8WZ42, Q90688, Q9JIF9, A2ASQ1, A3KN33, A8DYP0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
205 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 186 |
| Likely benign | 6 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4047 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:18706144:GGACT:G | acceptor_loss | 1.0000 |
| 11:18706147:C:CC | acceptor_gain | 1.0000 |
| 11:18706147:CT:C | acceptor_loss | 1.0000 |
| 11:18706907:GACT:G | donor_loss | 1.0000 |
| 11:18706908:ACT:A | donor_loss | 1.0000 |
| 11:18706909:CT:C | donor_loss | 1.0000 |
| 11:18706910:T:TG | donor_loss | 1.0000 |
| 11:18706911:CAC:C | donor_loss | 1.0000 |
| 11:18706912:A:AC | donor_gain | 1.0000 |
| 11:18706912:A:C | donor_loss | 1.0000 |
| 11:18706912:ACT:A | donor_gain | 1.0000 |
| 11:18706913:C:CA | donor_gain | 1.0000 |
| 11:18706913:CT:C | donor_gain | 1.0000 |
| 11:18706913:CTC:C | donor_gain | 1.0000 |
| 11:18706913:CTCT:C | donor_gain | 1.0000 |
| 11:18706913:CTCTG:C | donor_gain | 1.0000 |
| 11:18706919:T:TA | donor_gain | 1.0000 |
| 11:18706924:A:AC | donor_gain | 1.0000 |
| 11:18706961:CTG:C | donor_gain | 1.0000 |
| 11:18706962:TGT:T | donor_gain | 1.0000 |
| 11:18707004:T:TA | donor_gain | 1.0000 |
| 11:18707214:C:CC | acceptor_gain | 1.0000 |
| 11:18707214:CTGGA:C | acceptor_loss | 1.0000 |
| 11:18707215:T:A | acceptor_loss | 1.0000 |
| 11:18708205:A:AC | donor_gain | 1.0000 |
| 11:18708206:C:CC | donor_gain | 1.0000 |
| 11:18709684:C:CC | acceptor_gain | 1.0000 |
| 11:18710325:A:AC | donor_gain | 1.0000 |
| 11:18710326:C:CC | donor_gain | 1.0000 |
| 11:18710326:CTAA:C | donor_gain | 1.0000 |
AlphaMissense
8766 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:18716817:A:G | L386P | 1.000 |
| 11:18709464:C:G | R873P | 0.999 |
| 11:18710388:A:C | N779K | 0.999 |
| 11:18710388:A:T | N779K | 0.999 |
| 11:18710404:C:G | R774P | 0.999 |
| 11:18710407:A:G | F773S | 0.999 |
| 11:18713895:A:C | N684K | 0.999 |
| 11:18713895:A:T | N684K | 0.999 |
| 11:18713953:A:G | L665P | 0.999 |
| 11:18714026:A:G | W641R | 0.999 |
| 11:18714026:A:T | W641R | 0.999 |
| 11:18714328:A:C | Y583D | 0.999 |
| 11:18714366:A:G | L570P | 0.999 |
| 11:18714520:A:G | W546R | 0.999 |
| 11:18714520:A:T | W546R | 0.999 |
| 11:18715501:A:C | Y488D | 0.999 |
| 11:18715539:A:G | L475P | 0.999 |
| 11:18715612:A:G | W451R | 0.999 |
| 11:18715612:A:T | W451R | 0.999 |
| 11:18716739:A:G | L412P | 0.999 |
| 11:18716896:A:G | W360R | 0.999 |
| 11:18716896:A:T | W360R | 0.999 |
| 11:18717942:A:G | L321P | 0.999 |
| 11:18717982:A:C | Y308D | 0.999 |
| 11:18718020:A:G | L295P | 0.999 |
| 11:18718623:A:G | W268R | 0.999 |
| 11:18718623:A:T | W268R | 0.999 |
| 11:18721539:A:G | L125P | 0.999 |
| 11:18721613:C:A | W100C | 0.999 |
| 11:18721613:C:G | W100C | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000002455 (11:18713766 G>C), RS1000029786 (11:18717364 A>C), RS1000033826 (11:18713951 T>C), RS1000161450 (11:18719513 C>T), RS1000306632 (11:18726244 T>C), RS1000358590 (11:18726400 G>A), RS1000724287 (11:18706153 G>A,C), RS1000884315 (11:18712685 G>C), RS1001042095 (11:18715005 C>T), RS1001070876 (11:18718519 T>A), RS1001103026 (11:18708581 T>C), RS1001130191 (11:18725980 C>T), RS1001155316 (11:18705859 C>T), RS1001417261 (11:18714695 G>A,C), RS1001438714 (11:18718964 T>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003098_15 | Diabetic kidney disease | 5.000000e-06 |
| GCST010002_232 | Refractive error | 2.000000e-27 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| fluorene-9-bisphenol | decreases expression | 1 |
| propionaldehyde | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression, affects response to substance | 1 |
| abrine | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
| Lead | affects expression | 1 |
| Lipopolysaccharides | increases expression, decreases expression, affects response to substance | 1 |
| Naphthoquinones | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): diabetic kidney disease